The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Century Therapeutics's quick ratio for the quarter that ended in Jun. 2023 was 8.42.
Century Therapeutics has a quick ratio of 8.42. It generally indicates good short-term financial strength.
The historical rank and industry rank for Century Therapeutics's Quick Ratio or its related term are showing as below:
IPSC'
s Quick Ratio Range Over the Past 10 Years
Min: 6.51 Med: 14.46 Max: 28.1
Current: 8.42
During the past 4 years, Century Therapeutics's highest Quick Ratio was 28.10. The lowest was 6.51. And the median was 14.46.
IPSC's Quick Ratio is ranked better than 73.56% of 1585
companies
in the Biotechnology industry
Industry Median: 3.79
vs IPSC: 8.42
Century Therapeutics Quick Ratio Historical Data
The historical data trend for Century Therapeutics's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Century Therapeutics Annual Data
Trend
Dec19
Dec20
Dec21
Dec22
Quick Ratio
28.10
6.51
14.57
10.72
Century Therapeutics Quarterly Data
Jun19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Quick Ratio
17.79
13.44
10.72
9.24
8.42
Competitive Comparison
For the Biotechnology subindustry, Century Therapeutics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Century Therapeutics Quick Ratio Distribution
For the Biotechnology industry and Healthcare sector, Century Therapeutics's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Century Therapeutics's Quick Ratio falls in comparison to its industry or sector. The grey bar indicates the Quick Ratio's extreme value range as defined by GuruFocus.
Century Therapeutics Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Century Therapeutics's Quick Ratio for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Century Therapeutics (NAS:IPSC) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Century Therapeutics Quick Ratio Related Terms
Thank you for viewing the detailed overview of Century Therapeutics's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Century Therapeutics (NAS:IPSC) Business Description
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
0(0%) Volume: 103,422 11:09PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
IPSC has been successfully added to your 
